An Ultrapotent, Ultraeconomical, Antifreeze Polypeptide

T Thomas J. McPartlon (Department of Molecular Pharmaceutics University of Utah Salt Lake City UT 84112 USA) C Charles T. Osborne (Department of Biomedical Engineering University of Utah Salt Lake City UT 84112 USA) K Ke Wang (Tianjin Medical University Cancer Institute and Hospital Tianjin China) R Rachel E. Detwiler (Department of Biomedical Engineering University of Utah Salt Lake City UT 84112 USA) K Konrad Meister (Department of Chemistry and Biochemistry Boise State University Boise ID 83725 USA) J Jessica R. Kramer (Department of Molecular Pharmaceutics University of Utah Salt Lake City UT 84112 USA)

Abstract

Abstract The growth of large ice crystals during freeze and thaw events is a challenge in diverse settings from transportation and agriculture to foods and biomedicine. Design, synthesis, and evaluation of antifreeze polypeptides that inhibit ice crystal growth at µg concentrations are reported herein. The polypeptides, composed of Ala and Glu, are prepared using economical methodology, are stable after thermal events, are biodegradable, and are nontoxic to human cells. Mirror‐image polypeptides have resisted degradation and are suitable for applications with a longevity criterion. Their α‐helical conformation plays a role in antifreeze activity, but chirality does not. In proof‐of‐concept experiments, the antifreeze polypeptides could prevent damage to model protein therapeutics during repeated freeze–thaw cycles and could be applied to prevent large ice crystals in a frozen food product. These simple, economical Ala/Glu polypeptides are promising materials for diverse antifreeze applications, particularly in biological settings.

Article Details

Volume / Issue Vol. 38, Issue 4
Published January 01, 2026
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (6)

T

Thomas J. McPartlon

Department of Molecular Pharmaceutics University of Utah Salt Lake City UT 84112 USA

C

Charles T. Osborne

Department of Biomedical Engineering University of Utah Salt Lake City UT 84112 USA

K

Ke Wang

Tianjin Medical University Cancer Institute and Hospital Tianjin China

R

Rachel E. Detwiler

Department of Biomedical Engineering University of Utah Salt Lake City UT 84112 USA

K

Konrad Meister

Department of Chemistry and Biochemistry Boise State University Boise ID 83725 USA

J

Jessica R. Kramer

Department of Molecular Pharmaceutics University of Utah Salt Lake City UT 84112 USA